British Journal of Haematology

Leukaemia cutis with chronic myelomonocytic leukaemia
pp. 413-413(1)
Authors: Mahmood, Shameem; Cooper, Ashley; Ireland, Robin; Pocock, Christopher

Renal infiltration associated with chronic myelomonocytic leukaemia
pp. 414-414(1)
Authors: Kobayashi, Kichinosuke; Yokote, Taiji; Tsuji, Motomu; Takubo, Takayuki; Inoue, Toru; Hanafusa, Toshiaki

New insights into the haemostatic function of platelets
pp. 415-430(16)
Authors: Wei, Andrew H.; Schoenwaelder, Simone M.; Andrews, Robert K.; Jackson, Shaun P.

Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill
pp. 431-443(13)
Authors: Benson, Alexander B.; Moss, Marc; Silliman, Christopher C.

Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia
pp. 444-449(6)
Authors: Anderson, Lesley A.; Landgren, Ola; Engels, Eric A.

A new polycythaemia vera-associated SOCS3 SH2 mutant (SOCS3^F136L) cannot regulate erythropoietin responses
pp. 450-458(9)
Authors: Suessmuth, Yvonne; Elliott, Joanne; Percy, Melanie J.; Inami, Mitsuharu; Attal, Hila; Harrison, Claire N.; Inokuchi, Koiti; McMullin, Mary-Frances; Johnston, James A.

The anti-leukaemic activity of novel synthetic naphthoquinones against acute myeloid leukaemia: induction of cell death via the triggering of multiple signalling pathways
pp. 459-470(12)
Authors: Hallak, Maher; Win, Thida; Shpilberg, Ofer; Bittner, Shmuel; Granot, Yosef; Levy, Itai; Nathan, Ilana

Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression
pp. 471-483(13)
Authors: Ding, Wei; Nowakowski, Grzegorz S.; Knox, Traci R.; Boysen, Justin C.; Maas, Mary L.; Schwager, Susan M.; Wu, Wenting; Wellik, Linda E.; Dietz, Allan B.; Ghosh, Asish K.; Secreto, Charla R.; Medina, Kay L.; Shanafelt, Tait D.; Zent, Clive S.; Call, Timothy G.; Kay, Neil E.

Evidence for a novel mechanism for gene amplification in multiple myeloma: 1q12 pericentromeric heterochromatin mediates breakage-fusion-bridge cycles of a 1q12∼23 amplicon
pp. 484-494(11)
Authors: Sawyer, Jeffrey R.; Tian, Erming; Thomas, Edward; Koller, Mark; Stangeby, Colin; Sammartino, Gael; Goosen, Linda; Swanson, Charles; Binz, Regina L.; Barlogie, Bart; Shaughnessy, John

Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms
pp. 495-506(12)
Authors: Grimwade, Lizz F.; Happerfield, Lisa; Tristram, Colin; McIntosh, Gary; Rees, Mark; Bench, Anthony J.; Boyd, Elaine M.; Hall, Marie; Quinn, Amy; Piggott, Nigel; Scorer, Paul; Scott, Mike A.; Erber, Wendy N.

Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia
pp. 507-514(8)
Authors: Blum, Kristie A.; Advani, Anjani; Fernandez, Louis; Van Der Jagt, Richard; Brandwein, Joseph; Kambhampati, Suman; Kassis, Jeannine; Davis, Melanie; Bonfils, Claire; Dubay, Marja; Dumouchel, Julie; Drouin, Michel; Lucas, David M.; Martell, Robert E.; Byrd, John C.

Expression of histone deacetylases in lymphoma: implication for the development of selective inhibitors
pp. 515-525(11)
Authors: Gloghini, Annunziata; Buglio, Daniela; Khaskhely, Noor M.; Georgakis, Georgios; Orlowski, Robert Z.; Neelapu, Sattva S.; Carbone, Antonino; Younes, Anas

Associated cancers in parents and offspring of polycythaemia vera and myelofibrosis patients
pp. 526-530(5)
Authors: Hemminki, Kari; Sundquist, Jan; Bermejo, Justo L.

Impact of prior therapies on the relative efficacy of bortezomib compared with dexamethasone in patients with relapsed/refractory multiple myeloma
pp. 531-534(4)
Authors: Vogl, Dan T.; Stadtmauer, Edward A.; Richardson, Paul G.; Sonneveld, Pieter; Schuster, Michael W.; Irwin, David; Facon, Thierry; Harousseau, Jean-Luc; Boral, Anthony; Neuwirth, Rachel; Anderson, Kenneth C.

Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia
pp. 535-542(8)
Authors: Xia, Jun; Bolyard, Audrey A.; Rodger, Elin; Stein, Steve; Aprikyan, Andrew A.; Dale, David C.; Link, Daniel C.

High incidence of haemophagocytic syndrome following umbilical cord blood transplantation for adults
pp. 543-553(11)
Authors: Takagi, Shinsuke; Masuoka, Kazuhiro; Uchida, Naoyuki; Ishiwata, Kazuya; Araoka, Hideki; Tsuji, Masanori; Yamamoto, Hisashi; Kato, Daisuke; Matsuhashi, Yoshiko; Kusumi, Eiji; Ota, Yasunori; Seo, Sachiko; Matsumura, Tomoko; Matsuno, Naofumi; Wake, Atsushi; Miyakoshi, Shigesaburo; Makino, Shigeyoshi; Ohashi, Kenichi; Yoneyama, Akiko; Taniguchi, Shuichi

Absence of VOD in paediatric thalassaemic HSCT recipients using defibrotide prophylaxis and intravenous Busulphan
pp. 554-560(7)
Authors: Cappelli, Barbara; Chiesa, Robert; Evangelio, Costanza; Biffi, Alessandra; Roccia, Tito; Frugnoli, Ilaria; Biral, Erika; Noè, Anna; Fossati, Marco; Finizio, Valentina; Miniero, Roberto; Napolitano, Sara; Ferrua, Francesca; Soliman, Clara; Ciceri, Fabio; Roncarolo, Maria G.; Marktel, Sarah

Timing of initiation of enzyme replacement therapy after diagnosis of type 1 Gaucher disease: effect on incidence of avascular necrosis
pp. 561-570(10)
Authors: Mistry, Pramod K.; Deegan, Patrick; Vellodi, Ashok; Cole, J. Alexander; Yeh, Michael; Weinreb, Neal J.

Suppression of the hepcidin-encoding gene Hamp permits iron overload in mice lacking both hemojuvelin and matriptase-2/TMPRSS6
pp. 571-581(11)
Authors: Truksa, Jaroslav; Gelbart, Terri; Peng, Hongfan; Beutler, Ernest; Beutler, Bruce; Lee, Pauline

Rate of change of sickle allele frequency may be influenced by total fertility rate: a sesquicentenary reflection on human micro-evolution
pp. 582-583(2)
Authors: McKenzie, Colin A.; Hanchard, Neil A.; Harding, Rosalind; Hambleton, Ian; Modell, Bernadette

Concurrent thrombotic thrombocytopenic purpura and antiphospholipid syndrome: a rare and severe clinical combination
pp. 584-585(2)
Authors: Díaz-Cremades, Juan; Fernández-Fuertes, Fernando; Ruano, José A.; Tapia, Manuel; Soler, Santiago; Bosch, José M.; Caballero, Mar; González-San Miguel, José D.

Toll-like Receptors (TLRs) are expressed by myeloid leukaemia cell lines, but fail to trigger differentiation in response to the respective TLR ligands
pp. 585-587(3)
Authors: Okamoto, Masashi; Hirai, Hideyo; Taniguchi, Kyoko; Shimura, Kazuho; Inaba, Tohru; Shimazaki, Chihiro; Taniwaki, Masafumi; Imanishi, Jiro

Double de novo mutations of ELANE (ELA2) in a patient with severe congenital neutropenia requiring high-dose G-CSF therapy
pp. 587-590(4)
Authors: Lundén, Lina; Boxhammer, Sandra; Carlsson, Göran; Ellström, Karl-Gustav; Nordenskjöld, Magnus; Lagerstedt-Robinson, Kristina; Fadeel, Bengt